Scheman Andrew, Hipolito Ricky, Severson David, Youkhanis Nineveh
From the *Northwestern University Medical Center, Chicago, IL; †Department of Health, Research Institute for Tropical Medicine, Muntinlupa, Philippines; and §University of Illinois, Urbana-Champaign, IL.
Dermatitis. 2017 Mar-Apr;28(2):128-140. doi: 10.1097/DER.0000000000000254.
We discuss cross-reactions that can occur when a patient allergic to a specific allergen also reacts to a similar allergen. Currently, The American Contact Dermatitis Society Contact Allergy Management Program, which allows physicians to identify safe products for their patients, uses a 10% threshold to distinguish significant cross-reactors. New clinical data from a patch testing center along with previous data in the literature are analyzed to help determine whether current cross-reactor definitions are reasonable or should be altered.
我们讨论了对特定过敏原过敏的患者也会对相似过敏原产生反应时可能发生的交叉反应。目前，美国接触性皮炎学会接触性过敏管理项目允许医生为患者识别安全产品，该项目使用10%的阈值来区分显著交叉反应者。对一个斑贴试验中心的新临床数据以及文献中的既往数据进行分析，以帮助确定当前交叉反应者的定义是否合理或是否应该改变。
